decisionhealth Newsletters, Coder Pink Sheets - 2007 Issue 2 (February)
When to use 99211 with a protime: what the carriers say
Subscribe or sign in to view the full article.
Article Overview
This article explains how Medicare carriers have approached billing questions that arise during routine anticoagulation monitoring visits. It focuses on the type of documentation and visit context that may make a separate nursing/E&M service relevant, along with situations carriers have identified as not separately payable. The content is intended for coders, billing staff, and clinical practices that manage patients on anticoagulant therapy and need to understand carrier perspectives and documentation expectations.
Why This Topic Matters
Anticoagulation follow-up is common, high-volume, and closely reviewed by payers. Understanding carrier guidance can help practices recognize when a visit may warrant separate reporting and when the service is part of routine monitoring.
Article Sections
-
Overview of carrier scrutiny
Introduces the billing issue in routine anticoagulation management and explains why Medicare carrier attention is focused on this type of service.
-
General guidance on routine billing patterns
Summarizes carrier comments about repetitive documentation, blanket billing approaches, and the need for visit-specific records.
-
Situations discussed as appropriate for a separate E/M service
Reviews the kinds of visit circumstances described by carriers as potentially supporting a separately reported nursing or E/M encounter.
-
Situations discussed as not separately payable
Covers examples of routine monitoring scenarios that carriers describe as not warranting separate payment.
-
Incident-to and supervision considerations
Addresses the role of incident-to requirements and physician supervision in this setting.
-
Telephone follow-up and laboratory review
Notes carrier guidance related to management by phone and review of test results after the visit.
What You Will Learn
- How Medicare carrier guidance frames billing during anticoagulation monitoring visits
- What kinds of documentation themes carriers emphasize for these encounters
- Which general visit scenarios are discussed as potentially supporting separate reporting
- Which general visit scenarios are discussed as routine monitoring rather than separately payable
- Why incident-to and supervision concepts matter in this setting
- How telephone follow-up is treated in the context of laboratory result review
Who Should Read This
- Medical coders
- Billing staff
- Practice managers
- Cardiology practices
- Anticoagulation clinic staff
- Nursing staff involved in office visits
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com